Skip to main content

Table 3 Summary of responses after SEMS implantation

From: An outcome analysis of self-expandable metallic stents in central airway obstruction: a cohort study

Response

Total (n = 211)

Benign (n = 116)

Malignant (n = 95)

p value¶

Resolution of symptom, n(%)

138(65.4)

89(76.7)

49(51.6)

<. 0001

Complication related to SEMS in 30 days, n(%)

14(6.6)

5(4.3)

9(9.5)

0.134

Complication related to SEMS in 60 days, n(%)

25(11.8)

10(8.6)

15(15.8)

0.109

Overall complications related to SEMS, n(%)

69(32.7)

49(42.2)

20(21.1)

.0011

Time to complications developed, median (IQR)

87(33-435)

211(52-686)

33(15-59)

.0002

Complication episode per patient per month

0.006

0.008

0.01

-

  1. Abbreviations: IQR, Interquartile range; p value, benign group vs. malignant group; SEMS, self-expandable metallic stent